OpenURL Connection Search

Select item for more details and to access through your institution.

Atractylenolide-1 Targets FLT3 to Regulate PI3K/AKT/HIF1-α Pathway to Inhibit Osteogenic Differentiation of Human Valve Interstitial Cells.
Published in:
Frontiers in Pharmacology, 2022, v. 13, p. 1, doi. 10.3389/fphar.2022.899775
By:
- Wang, Jie;
- Zhang, Penghua;
- Zhang, Jing;
- Ma, Zhaohui;
- Tian, Xingqin;
- Liu, Yan;
- Lv, Guanghui;
- Qu, Linghang
Publication type:
Article
Deep-Fried Atractylodis Rhizoma Protects against Spleen Deficiency-Induced Diarrhea through Regulating Intestinal Inflammatory Response and Gut Microbiota.
Published in:
International Journal of Molecular Sciences, 2020, v. 21, n. 1, p. 124, doi. 10.3390/ijms21010124
By:
- Shi, Kun;
- Qu, Linghang;
- Lin, Xiong;
- Xie, Ying;
- Tu, Jiyuan;
- Liu, Xianqiong;
- Zhou, Zhongshi;
- Cao, Guosheng;
- Li, Shuiqing;
- Liu, Yanju
Publication type:
Article
Atractylodin Attenuates Dextran Sulfate Sodium-Induced Colitis by Alleviating Gut Microbiota Dysbiosis and Inhibiting Inflammatory Response Through the MAPK Pathway.
Published in:
Frontiers in Pharmacology, 2021, v. 12, p. 1, doi. 10.3389/fphar.2021.665376
By:
- Qu, Linghang;
- Lin, Xiong;
- Liu, Chunlian;
- Ke, Chang;
- Zhou, Zhongshi;
- Xu, Kang;
- Cao, Guosheng;
- Liu, Yanju
Publication type:
Article
Treatment of Spleen-Deficiency Syndrome With Atractyloside A From Bran-Processed Atractylodes lancea by Protection of the Intestinal Mucosal Barrier.
Published in:
Frontiers in Pharmacology, 2020, v. 11, p. N.PAG, doi. 10.3389/fphar.2020.583160
By:
- Tu, Jiyuan;
- Xie, Ying;
- Xu, Kang;
- Qu, Linghang;
- Lin, Xiong;
- Ke, Chang;
- Yang, Desen;
- Cao, Guosheng;
- Zhou, Zhongshi;
- Liu, Yanju
Publication type:
Article
Dehydroevodiamine Targeting ACHE and ALDH3A1 Regulate Glycolytic Metabolism to Inhibit Hepatocellular Carcinoma Cell Apoptosis.
Published in:
Natural Product Communications, 2023, v. 18, n. 8, p. 1, doi. 10.1177/1934578X231195153
By:
- Liu, Miaomiao;
- Cui, Yuexi;
- Xie, Zhoutao;
- Zheng, Yong;
- Chen, Hui;
- Wei, Meng;
- Xu, Kang;
- Qu, Linghang
Publication type:
Article
Atractylodes lancea Rhizoma Attenuates DSS-Induced Colitis by Regulating Intestinal Flora and Metabolites.
Published in:
American Journal of Chinese Medicine, 2022, v. 50, n. 2, p. 525, doi. 10.1142/S0192415X22500203
By:
- Qu, Linghang;
- Liu, Chunlian;
- Ke, Chang;
- Zhan, Xin;
- Li, Lanqing;
- Xu, Haiying;
- Xu, Kang;
- Liu, Yanju
Publication type:
Article
Atractylenolide‐1 affects glycolysis/gluconeogenesis by downregulating the expression of TPI1 and GPI to inhibit the proliferation and invasion of human triple‐negative breast cancer cells.
Published in:
Phytotherapy Research, 2023, v. 37, n. 3, p. 820, doi. 10.1002/ptr.7661
By:
- Xu, Haiying;
- Li, Lanqing;
- Qu, Linghang;
- Tu, Jiyuan;
- Sun, Xiongjie;
- Liu, Xianqiong;
- Xu, Kang
Publication type:
Article
Atractylodin targets GLA to regulate D‐mannose metabolism to inhibit osteogenic differentiation of human valve interstitial cells and ameliorate aortic valve calcification.
Published in:
Phytotherapy Research, 2023, v. 37, n. 2, p. 477, doi. 10.1002/ptr.7628
By:
- Qu, Linghang;
- Wang, Chunli;
- Xu, Haiying;
- Li, Lanqing;
- Liu, Yanju;
- Wan, Qianyun;
- Xu, Kang
Publication type:
Article
Andrographolide regulates H3 histone lactylation by interfering with p300 to alleviate aortic valve calcification.
Published in:
British Journal of Pharmacology, 2024, v. 181, n. 12, p. 1843, doi. 10.1111/bph.16332
By:
- Wang, Chunli;
- Wang, Shunshun;
- Wang, Zijun;
- Han, Juanjuan;
- Jiang, Nan;
- Qu, Linghang;
- Xu, Kang
Publication type:
Article
Daidzin inhibits hepatocellular carcinoma survival by interfering with the glycolytic/gluconeogenic pathway through downregulation of TPI1.
Published in:
Biofactors, 2022, v. 48, n. 4, p. 883, doi. 10.1002/biof.1826
By:
- Li, Lanqing;
- Xu, Haiying;
- Qu, Linghang;
- Xu, Kang;
- Liu, Xianqiong
Publication type:
Article

Found: 10